Fusion Pharmaceuticals Research Centres
Provides accessible, scientific, and confidential interactive therapy program for depression online.
Founded Date:
01.01.2014
Investor Type:
For Profit
Estimated Revenue:
$1M to $10M
Total Funding:
$170.9M
Investors Number:
16
Employee Number:
11-50
Last Funding Type:
Venture - Series Unknown
Industry:
Deep Diagnostics
Technology:
Genetic Test & Molecular Diagnostics
Headquarters:
Canada
Funding Status:
IPO